π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The primary objective of this study is to identify a new radioligand for im...
Status
Withdrawn
Location
John Hopkins Hospital
Start Date
2020-01
Trial ID
NCT03939780
Treatments Being Tested
Intravitreal topotecan exhibits strong anti-inflammatory, anti-proliferativ...
Status
Not Yet Recruiting
Location
St. Michael's Hospital
Start Date
2025-03
Trial ID
NCT06818721
Treatments Being Tested
This is a Phase IV real-world, observational, non-interventional, prospecti...
Status
Terminated
Location
Research Site
Start Date
2021-05-31
Trial ID
NCT04877743
Treatments Being Tested
This study will collect the data from existing patient medical records at U...
Status
Completed
Location
Research Site
Start Date
2023-07-10
Trial ID
NCT05775549
Treatments Being Tested
Primary \- To investigate the safety and tolerability of LCB01-0371 after ...
Status
Completed
Location
Asan Medical Center
Start Date
2012-03
Trial ID
NCT01554995
Treatments Being Tested
This is a worldwide, multicenter, non-interventional, retrospective study o...
Status
Completed
Location
Research Site
Start Date
2021-05-28
Trial ID
NCT04807595
Treatments Being Tested
The gut microbiota plays a key role in immunity and metabolism and contribu...
Status
Not Yet Recruiting
Location
Catholic University of the Sacred Heart
Start Date
2026-04-23
Trial ID
NCT06992453
Treatments Being Tested
This is an open label, multi-institutional, single arm study of dose escala...
Status
Completed
Location
Northwestern University, Robert H. Lurie Cancer Center
Start Date
2015-03
Trial ID
NCT02348008
Treatments Being Tested
CYTOMARK, a non-invasive in vitro diagnostic (IVD) test measuring a defined...
Status
Recruiting
Location
Hospital Universitari de Bellvitge
Start Date
2024-06-24
Trial ID
NCT07148154
Treatments Being Tested
ASPIRE will be a multi-site, prospective, two-part longitudinal, noninterve...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-30
Trial ID
NCT07669935
Treatments Being Tested